Prestige Consumer Healthcare Inc. (PBH)Healthcare | Drug Manufacturers - Specialty & Generic | Tarrytown, United States | NYSE
58.13 USD
+1.08
(1.893%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 57.99 -0.14 (-0.135%) ⇩ (April 17, 2026, 6:27 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:33 p.m. EDT
Prestige Consumer Healthcare (PBH) is a fundamental underperformer currently, weighing on technicals with the price trading well below its 50-day and 200-day averages (-10% downside versus 32% one-year drop). Valuation metrics (Forward P/E ~12x) are decent, but the lack of dividends and negative earnings growth (-23.5%) prevent a 'buy' recommendation until the earnings story stabilizes. While institutional buying by giants like JPMorgan and MA notes potential, the choices data signals a bearish bias for the next few months; the safest play is to wait for a confirmed technical reversal above the 50-day average or confirmation of the reported Breathe Right acquisition synergy before re-engaging. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.065032 |
| AutoARIMA | 0.065105 |
| AutoETS | 0.065105 |
| AutoTheta | 0.065985 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 7.35 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.241 |
| Excess Kurtosis | -0.87 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2013-12-26 |
| Debt to Equity Ratio | 58.995 |
| Revenue per Share | 22.519 |
| Market Cap | 2,795,123,712 |
| Trailing P/E | 15.34 |
| Forward P/E | 12.09 |
| Beta | 0.47 |
| Profit Margins | 16.90% |
| Website | https://www.prestigebrands.com |
As of April 18, 2026, 11:33 p.m. EDT: Options flow shows limited directional conviction in the near term. For the May 15 expiration, Open Interest (OI) is negligible across the board, suggesting a flat over/under with little immediate catalyst pricing. However, the July 17 expiration reveals a stark divergence: significant Implied Put OI (138 contracts) at the $65 strike compared to virtually zero Call OI for that horizon. This suggests speculators are defensively positioning for continued downside risk or regulatory headwinds over the longer near-term, despite the stock currently trading below the 79 key average target.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2601502 |
| Address1 | 660 White Plains Road |
| All Time High | 90.04 |
| All Time Low | 3.92 |
| Ask | 67.88 |
| Ask Size | 200 |
| Audit Risk | 2 |
| Average Daily Volume10 Day | 517,470 |
| Average Daily Volume3 Month | 480,345 |
| Average Volume | 480,345 |
| Average Volume10Days | 517,470 |
| Beta | 0.469 |
| Bid | 57.85 |
| Bid Size | 100 |
| Board Risk | 3 |
| Book Value | 38.662 |
| City | Tarrytown |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 58.13 |
| Current Ratio | 3.106 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 58.81 |
| Day Low | 57.35 |
| Debt To Equity | 58.995 |
| Display Name | Prestige Consumer Healthcare |
| Earnings Call Timestamp End | 1,770,298,200 |
| Earnings Call Timestamp Start | 1,770,298,200 |
| Earnings Growth | -0.205 |
| Earnings Quarterly Growth | -0.235 |
| Earnings Timestamp | 1,770,298,200 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda | 364,984,000 |
| Ebitda Margins | 0.33071998 |
| Enterprise To Ebitda | 10.323 |
| Enterprise To Revenue | 3.414 |
| Enterprise Value | 3,767,554,816 |
| Eps Current Year | 4.54 |
| Eps Forward | 4.81 |
| Eps Trailing Twelve Months | 3.79 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,388,102,400 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 62.952 |
| Fifty Day Average Change | -4.8219986 |
| Fifty Day Average Change Percent | -0.07659802 |
| Fifty Two Week Change Percent | -26.015018 |
| Fifty Two Week High | 89.37 |
| Fifty Two Week High Change | -31.240002 |
| Fifty Two Week High Change Percent | -0.34955803 |
| Fifty Two Week Low | 51.24 |
| Fifty Two Week Low Change | 6.8899994 |
| Fifty Two Week Low Change Percent | 0.13446525 |
| Fifty Two Week Range | 51.24 - 89.37 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,108,045,800,000 |
| Float Shares | 46,750,905 |
| Forward Eps | 4.81 |
| Forward P E | 12.085239 |
| Free Cashflow | 207,171,120 |
| Full Exchange Name | NYSE |
| Full Time Employees | 600 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.56986 |
| Gross Profits | 628,897,984 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.012990001 |
| Held Percent Institutions | 1.11516 |
| Implied Shares Outstanding | 48,084,011 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ir Website | http://ir.prestigebrands.com/phoenix.zhtml?c=182173&p=irol-irHome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Long Business Summary | Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. |
| Long Name | Prestige Consumer Healthcare Inc. |
| Market | us_market |
| Market Cap | 2,795,123,712 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_10969688 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 186,500,992 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 2,750,637,774 |
| Number Of Analyst Opinions | 6 |
| Open | 57.69 |
| Operating Cashflow | 276,633,984 |
| Operating Margins | 0.29103002 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.88 |
| Phone | 914 524 6800 |
| Post Market Change | -0.13515091 |
| Post Market Change Percent | -0.23249769 |
| Post Market Price | 57.99485 |
| Post Market Time | 1,776,464,821 |
| Previous Close | 57.05 |
| Price Eps Current Year | 12.803966 |
| Price Hint | 2 |
| Price To Book | 1.5035436 |
| Price To Sales Trailing12 Months | 2.532719 |
| Profit Margins | 0.16899 |
| Quick Ratio | 1.812 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 1.08 |
| Regular Market Change Percent | 1.89308 |
| Regular Market Day High | 58.81 |
| Regular Market Day Low | 57.35 |
| Regular Market Day Range | 57.35 - 58.81 |
| Regular Market Open | 57.69 |
| Regular Market Previous Close | 57.05 |
| Regular Market Price | 58.13 |
| Regular Market Time | 1,776,456,002 |
| Regular Market Volume | 246,018 |
| Return On Assets | 0.061329998 |
| Return On Equity | 0.1031 |
| Revenue Growth | -0.024 |
| Revenue Per Share | 22.519 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 47,318,730 |
| Shares Percent Shares Out | 0.056900002 |
| Shares Short | 2,692,183 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,374,940 |
| Short Name | Prestige Consumer Healthcare In |
| Short Percent Of Float | 0.0804 |
| Short Ratio | 5.78 |
| Source Interval | 15 |
| State | NY |
| Symbol | PBH |
| Target High Price | 86.0 |
| Target Low Price | 66.0 |
| Target Mean Price | 78.5 |
| Target Median Price | 79.0 |
| Total Cash | 62,373,000 |
| Total Cash Per Share | 1.318 |
| Total Debt | 1,079,289,984 |
| Total Revenue | 1,103,606,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.79 |
| Trailing P E | 15.337731 |
| Trailing Peg Ratio | 1.8788 |
| Triggerable | 1 |
| Two Hundred Day Average | 64.6298 |
| Two Hundred Day Average Change | -6.499798 |
| Two Hundred Day Average Change Percent | -0.10056967 |
| Type Disp | Equity |
| Volume | 246,018 |
| Website | https://www.prestigebrands.com |
| Zip | 10,591 |